Involvement of CD40-CD40 Ligand in uncomplicated and refractory celiac disease

Antonio Di Sabatino, Laura Rovedatti, Stefania Vetrano, Francesca Vidali, Paolo Biancheri, Maria Rescigno, Silvio Danese, Thomas T. MacDonald, Gino R. Corazza

Research output: Contribution to journalArticle

Abstract

Objectives:Cognate interaction between CD40 on antigen-presenting cells and CD40 ligand (CD40L) on T cells is a crucial costimulatory signal in T-cell activation. In this study, we investigated CD40-CD40L expression in the duodenum of uncomplicated and refractory celiac disease patients, and explored the ex vivo effects of CD40L blockade on cytokine production and the T-helper cell type 1-specific transcription factor T-bet.Methods:CD40L and colocalization of CD40 with the dendritic cell markers CD11c and CD123 were investigated by confocal microscopy on tissue sections of duodenal biopsy samples obtained from 14 uncomplicated celiac patients before and after 12 months of gluten-free diet, 5 refractory celiac patients, and 12 controls. CD40 was also analyzed by flow cytometry on single cell suspension of mucosal biopsies. Treated celiac biopsies were stimulated with peptic-tryptic digest of gliadin (PT-gliadin) with or without an anti-CD40L-neutralizing antibody. Interferon (IFN)-γ and interleukin (IL)-17 were measured by ELISA (enzyme-linked immunosorbent assay). T-bet, CD40, and CD40L were determined by immunoblotting.Results:CD40 and CD40L expression was higher in uncomplicated untreated and refractory celiac patients than in controls; the expression returned to normal after gluten-free diet in uncomplicated patients. Flow cytometric analysis confirmed that most CD40 cells were dendritic cells. The addition of the anti-CD40L antibody to treated celiac biopsies significantly inhibited the PT-gliadin-induced production of IFN-γ and IL-17, and mucosal T-bet.Conclusions:Our results indicate that the CD40-CD40L pathway has a key role in celiac disease. Disruption of CD40-CD40L interaction may offer a therapeutic alternative in refractory celiac disease.

Original languageEnglish
Pages (from-to)519-527
Number of pages9
JournalAmerican Journal of Gastroenterology
Volume106
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

CD40 Ligand
Celiac Disease
Abdomen
Biopsy
Gliadin
Gluten-Free Diet
Interleukin-17
Dendritic Cells
Interferons
Digestion
CD40 Antigens
T Cell Transcription Factor 1
T-Lymphocytes
Antigen-Presenting Cells
Helper-Inducer T-Lymphocytes
Neutralizing Antibodies
Duodenum
Immunoblotting
Confocal Microscopy
Suspensions

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Involvement of CD40-CD40 Ligand in uncomplicated and refractory celiac disease. / Di Sabatino, Antonio; Rovedatti, Laura; Vetrano, Stefania; Vidali, Francesca; Biancheri, Paolo; Rescigno, Maria; Danese, Silvio; MacDonald, Thomas T.; Corazza, Gino R.

In: American Journal of Gastroenterology, Vol. 106, No. 3, 03.2011, p. 519-527.

Research output: Contribution to journalArticle

@article{4051809d4cbd46ce9ba73a94d531ada5,
title = "Involvement of CD40-CD40 Ligand in uncomplicated and refractory celiac disease",
abstract = "Objectives:Cognate interaction between CD40 on antigen-presenting cells and CD40 ligand (CD40L) on T cells is a crucial costimulatory signal in T-cell activation. In this study, we investigated CD40-CD40L expression in the duodenum of uncomplicated and refractory celiac disease patients, and explored the ex vivo effects of CD40L blockade on cytokine production and the T-helper cell type 1-specific transcription factor T-bet.Methods:CD40L and colocalization of CD40 with the dendritic cell markers CD11c and CD123 were investigated by confocal microscopy on tissue sections of duodenal biopsy samples obtained from 14 uncomplicated celiac patients before and after 12 months of gluten-free diet, 5 refractory celiac patients, and 12 controls. CD40 was also analyzed by flow cytometry on single cell suspension of mucosal biopsies. Treated celiac biopsies were stimulated with peptic-tryptic digest of gliadin (PT-gliadin) with or without an anti-CD40L-neutralizing antibody. Interferon (IFN)-γ and interleukin (IL)-17 were measured by ELISA (enzyme-linked immunosorbent assay). T-bet, CD40, and CD40L were determined by immunoblotting.Results:CD40 and CD40L expression was higher in uncomplicated untreated and refractory celiac patients than in controls; the expression returned to normal after gluten-free diet in uncomplicated patients. Flow cytometric analysis confirmed that most CD40 cells were dendritic cells. The addition of the anti-CD40L antibody to treated celiac biopsies significantly inhibited the PT-gliadin-induced production of IFN-γ and IL-17, and mucosal T-bet.Conclusions:Our results indicate that the CD40-CD40L pathway has a key role in celiac disease. Disruption of CD40-CD40L interaction may offer a therapeutic alternative in refractory celiac disease.",
author = "{Di Sabatino}, Antonio and Laura Rovedatti and Stefania Vetrano and Francesca Vidali and Paolo Biancheri and Maria Rescigno and Silvio Danese and MacDonald, {Thomas T.} and Corazza, {Gino R.}",
year = "2011",
month = "3",
doi = "10.1038/ajg.2010.450",
language = "English",
volume = "106",
pages = "519--527",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Involvement of CD40-CD40 Ligand in uncomplicated and refractory celiac disease

AU - Di Sabatino, Antonio

AU - Rovedatti, Laura

AU - Vetrano, Stefania

AU - Vidali, Francesca

AU - Biancheri, Paolo

AU - Rescigno, Maria

AU - Danese, Silvio

AU - MacDonald, Thomas T.

AU - Corazza, Gino R.

PY - 2011/3

Y1 - 2011/3

N2 - Objectives:Cognate interaction between CD40 on antigen-presenting cells and CD40 ligand (CD40L) on T cells is a crucial costimulatory signal in T-cell activation. In this study, we investigated CD40-CD40L expression in the duodenum of uncomplicated and refractory celiac disease patients, and explored the ex vivo effects of CD40L blockade on cytokine production and the T-helper cell type 1-specific transcription factor T-bet.Methods:CD40L and colocalization of CD40 with the dendritic cell markers CD11c and CD123 were investigated by confocal microscopy on tissue sections of duodenal biopsy samples obtained from 14 uncomplicated celiac patients before and after 12 months of gluten-free diet, 5 refractory celiac patients, and 12 controls. CD40 was also analyzed by flow cytometry on single cell suspension of mucosal biopsies. Treated celiac biopsies were stimulated with peptic-tryptic digest of gliadin (PT-gliadin) with or without an anti-CD40L-neutralizing antibody. Interferon (IFN)-γ and interleukin (IL)-17 were measured by ELISA (enzyme-linked immunosorbent assay). T-bet, CD40, and CD40L were determined by immunoblotting.Results:CD40 and CD40L expression was higher in uncomplicated untreated and refractory celiac patients than in controls; the expression returned to normal after gluten-free diet in uncomplicated patients. Flow cytometric analysis confirmed that most CD40 cells were dendritic cells. The addition of the anti-CD40L antibody to treated celiac biopsies significantly inhibited the PT-gliadin-induced production of IFN-γ and IL-17, and mucosal T-bet.Conclusions:Our results indicate that the CD40-CD40L pathway has a key role in celiac disease. Disruption of CD40-CD40L interaction may offer a therapeutic alternative in refractory celiac disease.

AB - Objectives:Cognate interaction between CD40 on antigen-presenting cells and CD40 ligand (CD40L) on T cells is a crucial costimulatory signal in T-cell activation. In this study, we investigated CD40-CD40L expression in the duodenum of uncomplicated and refractory celiac disease patients, and explored the ex vivo effects of CD40L blockade on cytokine production and the T-helper cell type 1-specific transcription factor T-bet.Methods:CD40L and colocalization of CD40 with the dendritic cell markers CD11c and CD123 were investigated by confocal microscopy on tissue sections of duodenal biopsy samples obtained from 14 uncomplicated celiac patients before and after 12 months of gluten-free diet, 5 refractory celiac patients, and 12 controls. CD40 was also analyzed by flow cytometry on single cell suspension of mucosal biopsies. Treated celiac biopsies were stimulated with peptic-tryptic digest of gliadin (PT-gliadin) with or without an anti-CD40L-neutralizing antibody. Interferon (IFN)-γ and interleukin (IL)-17 were measured by ELISA (enzyme-linked immunosorbent assay). T-bet, CD40, and CD40L were determined by immunoblotting.Results:CD40 and CD40L expression was higher in uncomplicated untreated and refractory celiac patients than in controls; the expression returned to normal after gluten-free diet in uncomplicated patients. Flow cytometric analysis confirmed that most CD40 cells were dendritic cells. The addition of the anti-CD40L antibody to treated celiac biopsies significantly inhibited the PT-gliadin-induced production of IFN-γ and IL-17, and mucosal T-bet.Conclusions:Our results indicate that the CD40-CD40L pathway has a key role in celiac disease. Disruption of CD40-CD40L interaction may offer a therapeutic alternative in refractory celiac disease.

UR - http://www.scopus.com/inward/record.url?scp=79952362057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952362057&partnerID=8YFLogxK

U2 - 10.1038/ajg.2010.450

DO - 10.1038/ajg.2010.450

M3 - Article

C2 - 21139574

AN - SCOPUS:79952362057

VL - 106

SP - 519

EP - 527

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 3

ER -